Search images on Google      Product Monograph

Active Ingredients:

• sacituzumab govitecan, 180 MG/VIAL

DIN: 02520788

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Prescription

Company: GILEAD SCIENCES CANADA INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FX - (ATC, WHO)
• L01FX17 - SACITUZUMAB GOVITECAN (WHO)

Pharmaceutical standard: MFR

 

External Links for Trodelvy:

Search on Google

• Trodelvy side effects
• Trodelvy dosage
• sacituzumab govitecan side effects
• sacituzumab govitecan dosage